Advertisement

Pharmacy World and Science

, Volume 27, Issue 6, pp 442–446 | Cite as

Are Essential Medicines in Malaysia Accessible, Affordable and Available?

  • Kamaruzaman Saleh
  • Mohamed I. M. IbrahimEmail author
Research Article

Abstract

Objective:

To assess the pharmaceutical sector to know whether people have access to essential medicines.

Setting:

The study was conducted in 20 public health clinics, five public district drug stores and 20 private retail pharmacies selected randomly in five different areas randomly selected (four states and a federal territory).

Method:

The methodology used was adopted from the World Health Organization study protocol. The degree of attainment of the strategic pharmaceutical objectives of improved access is measured by a list of tested indicators. Access is measured in terms of the availability and affordability of essential medicines, especially to the poor and in the public sector. The first survey in the public health clinics and public district drug stores gathered information about current availability of essential medicines, prevalence of stock-outs and affordability of treatment (except drug stores). The second survey assessed affordability of treatment in public health clinics and private retail pharmacies.

Main Outcome Measure

Availability, stock-out duration, percent of medicines dispensed, accessibility and affordability of key medicines.

Results

The average availability of key medicines in the public health clinics for the country was 95.4%. The average stock-out duration of key medicines was 6.5 days. However, average availability of key medicines in the public district drug stores was 89.2%; with an average stock-out duration of 32.4 days. Medicines prescribed were 100% dispensed to the patients. Average affordability for public health clinics was 1.5 weeks salary and for the private pharmacies, 3.7 weeks salary.

Conclusions:

The present pharmaceutical situation in the context of essential medicines list implementation reflected that the majority of the population in Malaysia had access to affordable essential medicines. If medicines need to be obtained from the private sector, they are hardly affordable. Although the average availability of essential medicines in Malaysia was high being more than 95.0%, in certain areas in Sabah availability was less than 80.0% and still a problem.

Keywords

Drug accessibility Drug affordability Drug availability Essential drugs Essential medicines Malaysia Public health 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    WHO2000The use of essential medicines (Including the Revised Model List of Essential Medicines) Ninth Report of the WHO Expert CommitteeWorld Health OrganizationGenevaTechnical Report Series, No. 895Google Scholar
  2. 2.
    WHO. Twenty-five years of essential medicines progress. Essent Med Monit 2003; 32: 1.Google Scholar
  3. 3.
    Kindermans, JM, Matthys, F 2001Introductory note: The access to essential medicines campaignTrop Med Int Health69557CrossRefPubMedGoogle Scholar
  4. 4.
    Bennet, S, Quick, JD, Velasquez, G 1997Public-private roles in the pharmaceutical sector-implications for equitable access and rational medicine use. Health Economic and MedicinesAction Programme on Essential MedicinesGenevaWorld Health Organization; DAP Series No. 5-WHO/DAP/97.12Google Scholar
  5. 5.
    Balasubramaniam K. Strategies to ensure availability and affordability of safe and effective medicines of good quality in the Asia Pacific region. International Conference on Medicinal Medicine Policies – The Way Forward. Australian Prescriber, 1995; 20(Suppl  1).Google Scholar
  6. 6.
    WHO2001Core indicators on country pharmaceutical situationWorld Health OrganizationGenevaGoogle Scholar
  7. 7.
    Brudon, P, Rainhorn, JD, Reich, MR 1999Indicators for monitoring national medicine policies2World Health OrganizationGenevaWHO/EDM/PAR/99.3Google Scholar
  8. 8.
    MSH1995Rapid pharmaceutical assessment – an indicator-based approachManagement Sciences for HealthWashington, DCGoogle Scholar
  9. 9.
    Hardon, A, Brudon-Jakobowiz, P, Reeler, A 1992How to investigate medicine use in communities. Guideline for social researchGenevaWorld Health OrganizationWHO/DAP/92.3Google Scholar
  10. 10.
    Ministry of Health1996Antibiotic guidelines 1996Medical Consensus Development Panel, Ministry of Health Malaysia and Academic of MedicineMalaysiaGoogle Scholar
  11. 11.
    WHO. WHO Medicines strategic 2002–2003: Framework for action in essential medicines and medicines. http://www.who.int/medicines/strategy/strategy.pdf (3 November, 2002).
  12. 12.
    Pecoul, B, Chirac, P, Trouiller, P, Pinel, J 1999Access to essential medicines in poor countries. A lost battle?JAMA2813617CrossRefPubMedGoogle Scholar
  13. 13.
    WHO. Essential medicines and medicines policy: The rational for essential medicines. http://www.who.int/medicines/rationale.shtml (3 November, 2002).
  14. 14.
    Antezana, FS 1992Essential medicines: Action for equityWorld Health4578Google Scholar
  15. 15.
    Quick, JD 2003Essential medicines twenty-five years on: Closing the access gapHealth Pol Planning1813Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Social & Administrative Pharmacy, School of Pharmaceutical SciencesUniversiti Sains MalaysiaPenangMalaysia
  2. 2.National Pharmaceutical Control BureauJalan UniversitiSelangorMalaysia

Personalised recommendations